帕瑞昔布钠对经尿道前列腺切除术的镇痛和安全性的分析

Analgesic efficacy and safety of Parecoxib Sodium after transurethral resection of prostate

目的评价帕瑞昔布钠用于经尿道前列腺切除术的术后镇痛和安全性。方法将我院60例腰硬联合麻醉下行经尿道前列腺切除术的患者随机分为A组和B组。A组患者在麻醉诱导前30 min快速静脉注射溶解于2 mL生理盐水的40 mg帕瑞昔布钠;B组患者在麻醉诱导前30 min快速经脉注射2 mL生理盐水。记录术后30 min(T1),术后1 h(T2)、2 h(T3)、4 h(T4)和6 h(T5)的VAS评分,手术前和术后血红蛋白水平以及凝血功能指标(凝血酶原时间PT,国际标准化比率INR)。结果 A组在术后T1、T2、T3、T4和T5时间点的VAS评分均低于B组(P<0.05)。两组间切除组织的重量、手术时间、手术前后血红蛋白的水平和凝血功能指标差异无统计学意义(P>0.05)。两组术后均未额外输入红细胞。结论非甾体抗炎药帕瑞昔布钠可以安全用于经尿道前列腺切除术的术后镇痛。

Objective To assess the analgesic efficacy and safety of Parecoxib Sodium after transurethral resection of prostate.Methods 60 patients undergoing transurethral resection of prostate under spinal combined epidural anesthesia were randomly divided into group A and group B.Patients of group A were intravenous injected 40 mg Parecoxib Sodium that was dissolved in 2 mL Normal Saline before anesthesia induction 30 min.Patients of group B were intravenous injected 2 mL Normal Saline before anesthesia induction 30 min.Postoperative pain scores were evaluated at 30 min,1,2,4 and 6 hours after administration of each Analgesic,using a visual analogue scale（VAS）.Furthermore,preoperative and postoperative hemoglobin（Hb） levels and hemostatic variables [prothrombin time（PT） and the international normalized ratio（INR）] were recorded in all patients.Results The score of VAS of group A at the time of T1,T2,T3,T4,T5 were lower than that of group B,there were significant decreases（P〈0.05）.There was no significant difference on the amount of resection tissue,operating time,preoperative-postoperative Hb levels and hemostatic variables between the two groups.There was no patient required blood transfusion after operation in the two groups.Conclusion Parecoxib Sodium of NSAIDs has not a contraindication to TURP and should be used for the control of postoperative pain.